These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Executive/attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic first-degree relatives. Laurent A, Biloa-Tang M, Bougerol T, Duly D, Anchisi AM, Bosson JL, Pellat J, d'Amato T, Dalery J. Schizophr Res; 2000 Dec 15; 46(2-3):269-83. PubMed ID: 11120438 [Abstract] [Full Text] [Related]
15. WCST performance and schizotypal features in the first-degree relatives of patients with schizophrenia. Laurent A, Duly D, Murry P, Foussard N, Boccara S, Mingat F, Dalery J, d'Amato T. Psychiatry Res; 2001 Nov 01; 104(2):133-44. PubMed ID: 11711167 [Abstract] [Full Text] [Related]
16. Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia. Purdon SE, Valiakalayil A, Hanstock CC, Seres P, Tibbo P. Schizophr Res; 2008 Feb 01; 99(1-3):218-24. PubMed ID: 18248960 [Abstract] [Full Text] [Related]
18. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B. Encephale; 2008 Dec 01; 34(6):557-62. PubMed ID: 19081451 [Abstract] [Full Text] [Related]
19. Attentional deficits in patients with schizophrenia and in their non-psychotic first-degree relatives. Laurent A, Saoud M, Bougerol T, d'Amato T, Anchisi AM, Biloa-Tang M, Dalery J, Rochet T. Psychiatry Res; 1999 Dec 27; 89(3):147-59. PubMed ID: 10708262 [Abstract] [Full Text] [Related]